``financing with no apparent dilution ``. I guess ``technically`` this is correct. But reducing the revenue to the company has the same effect as dividing it by an increased number of shares. The royalty deal is equivalent (over simplified) to a 20% increase in the number of shares. We`re not cutting the pie up more, we just made the pie smaller.

Now, having said that, I too think that this is great news for shareholders. It indicates that someone has significant confidence in Medeviewer prospects going forward. Also, unlike increasing the float, this deal has a finite life. What would be the likelihood that EDIG could buy back an additional 20% of their stock three years from now?

I smell good news a comin`.

DoP